| |
| |
|
| Insider
Information: |
Lederman Seth |
| Relationship: |
Chief Executive Office... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
3,505 |
|
|
Indirect Shares
|
24,249 |
|
|
| Direct
Value |
$600 |
|
|
|
Indirect Value
|
$4,149 |
|
|
| Total
Shares |
27,754 |
|
|
| Total
Value |
$4,749 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tonix Pharmaceuticals Holding Corp |
TNXP |
Chief Executive Office... |
2022-06-29 |
3,505 |
2022-06-29 |
24,249 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2022-06-29 |
4 |
B |
$1.71 |
$34,200 |
I/I |
20,000 |
24,235 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2022-03-25 |
4 |
B |
$0.25 |
$24,500 |
D/D |
100,000 |
112,177 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2021-09-28 |
4 |
B |
$0.61 |
$7,320 |
D/D |
12,000 |
12,177 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2021-03-24 |
4 |
B |
$1.32 |
$22,088 |
I/I |
16,733 |
135,000 |
2.58 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2020-08-13 |
4 |
B |
$0.91 |
$54,600 |
I/I |
60,000 |
83,267 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2019-12-03 |
4 |
B |
$1.16 |
$23,180 |
I/I |
20,000 |
23,267 |
2.58 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2019-03-29 |
4 |
B |
$2.49 |
$12,440 |
I/I |
5,000 |
32,670 |
2.58 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2019-03-26 |
4 |
B |
$2.38 |
$59,375 |
I/I |
25,000 |
27,670 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2018-06-29 |
4 |
B |
$4.64 |
$2,320 |
D/D |
500 |
17,666 |
2.73 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2018-06-28 |
4 |
B |
$4.58 |
$2,290 |
D/D |
500 |
17,166 |
2.73 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2018-06-27 |
4 |
B |
$4.55 |
$2,275 |
D/D |
500 |
16,666 |
2.73 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2018-06-12 |
4 |
B |
$4.37 |
$4,370 |
D/D |
1,000 |
16,166 |
2.73 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2018-06-12 |
4 |
B |
$4.37 |
$8,740 |
I/I |
2,000 |
20,463 |
2.58 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2018-05-25 |
4 |
B |
$3.17 |
$12,680 |
I/I |
4,000 |
26,700 |
2.58 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2017-12-26 |
4 |
B |
$3.61 |
$19,133 |
I/I |
5,300 |
22,700 |
2.58 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2017-08-17 |
4 |
B |
$3.00 |
$45,068 |
I/I |
15,000 |
50,000 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2017-08-16 |
4 |
B |
$2.99 |
$14,950 |
I/I |
5,000 |
35,000 |
2.58 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2017-06-30 |
4 |
B |
$4.33 |
$21,640 |
I/I |
5,000 |
30,000 |
2.58 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2017-06-26 |
4 |
B |
$4.40 |
$22,000 |
I/I |
5,000 |
25,000 |
2.58 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2017-06-20 |
4 |
B |
$4.22 |
$84,400 |
I/I |
20,000 |
20,000 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2016-11-21 |
4 |
B |
$0.43 |
$41,924 |
I/I |
98,000 |
133,000 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2016-10-31 |
4 |
B |
$0.00 |
$0 |
D/D |
10,000 |
90,815 |
2.73 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2016-06-30 |
5 |
A |
$1.74 |
$5,735 |
D/D |
3,296 |
79,111 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2016-06-22 |
4 |
B |
$2.08 |
$41,500 |
I/I |
20,000 |
20,000 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2016-06-21 |
4 |
B |
$2.00 |
$50,000 |
I/I |
25,000 |
31,000 |
2.66 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
